Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer's, Parkinson's, and Huntington's disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015]
BDNF (Brain Derived Neurotrophic Factor) is a Protein Coding gene. Diseases associated with BDNF include Central Hypoventilation Syndrome, Congenital and Wilms Tumor, Aniridia, Genitourinary Anomalies, And Mental Retardation Syndrome. Among its related pathways are ERK Pathway in Huntingtons Disease and Guidance Cues and Growth Cone Motility. Gene Ontology (GO) annotations related to this gene include signaling receptor binding and neurotrophin TRKB receptor binding. An important paralog of this gene is NTF3.
Trk (neurotrophin) receptors are single transmembrane catalytic receptors with intracellular tyrosine kinase activity. Trk receptors are coupled to the Ras, Cdc42/Rac/RhoG, MAPK, PI3K and PLCgamma signaling pathways. Four members of the Trk family have been identified.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005102 | signaling receptor binding | IEA | -- |
GO:0005163 | nerve growth factor receptor binding | IBA | 21873635 |
GO:0005515 | protein binding | IPI | 25241761 |
GO:0008083 | growth factor activity | TAS,IBA | 21873635 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005576 | extracellular region | TAS | -- |
GO:0005615 | extracellular space | IBA | 21873635 |
GO:0005737 | cytoplasm | ISS | -- |
GO:0005739 | mitochondrion | IDA | -- |
GO:0008021 | synaptic vesicle | IBA | 21873635 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Apoptotic Pathways in Synovial Fibroblasts |
Cellular Apoptosis Pathway
.85
Mitochondrial Apoptosis
.85
Apoptotic Pathways in Synovial Fibroblasts
.84
p53 Mediated Apoptosis
.84
DHA Signaling
.74
Telomerase Components in Cell Signaling
.72
PPAR Pathway
.66
|
Rac1 Pathway
.65
Glioma Invasiveness
.64
Actin-Based Motility by Rho Family GTPases
.62
ERK5 Signaling
.61
eIF2 Pathway
.60
Rap1 Pathway
.57
Nuclear Receptor Activation by Vitamin-A
.57
|
2 | GPCR Pathway |
Paxillin Interactions
.73
Ras Pathway
.73
GPCR Pathway
.62
Pancreatic Adenocarcinoma
.59
|
Breast Cancer Regulation by Stathmin1
.58
NFAT in Immune Response
.58
Estrogen Pathway
.55
|
3 | ERK Signaling |
ERK Signaling
.61
Rho Family GTPases
.61
MAPK Signaling
.58
|
Molecular Mechanisms of Cancer
.51
ILK Signaling
.49
|
4 | Nanog in Mammalian ESC Pluripotency |
GSK3 Signaling
.62
Nanog in Mammalian ESC Pluripotency
.62
|
14-3-3 Induced Intracellular Signaling
.59
eNOS Signaling
.48
|
5 | CREB Pathway |
CREB Pathway
.68
IP3 Pathway
.68
|
Activation of PKC through GPCR
.63
Intracellular Calcium Signaling
.50
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0001657 | ureteric bud development | IEA | -- |
GO:0001662 | behavioral fear response | IEA | -- |
GO:0007165 | signal transduction | IEA | -- |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | IBA | 21873635 |
GO:0007202 | activation of phospholipase C activity | TAS | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Citalopram | Approved | Pharma | 597 | |||
Dopamine | Approved | Pharma | Agonist, Full agonist | 3978 | ||
Escitalopram | Approved | Pharma | 0 | |||
Ethanol | Approved | Pharma | 3266 | |||
Fluoxetine | Approved, Vet_approved | Pharma | Channel blocker, Antagonist, Inhibitor, Inhibition | 278 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
AG 879 |
|
148741-30-4 |
|
|
||
LM11A 31 dihydrochloride |
|
1243259-19-9 |
|
|
Compound | Action | Cas Number |
---|---|---|
AG 879 | TrkA inhibitor | 148741-30-4 |
BDNF (human) | Activates TrkB and p75 receptors | 218441-99-7 |
LM11A 31 dihydrochloride | Nonpeptide p75NTR ligand; neuroprotective | 1243259-19-9 |
TLQP 21 | VGF-derived peptide | 869988-94-3 |
Compound | Action | Cas Number |
---|---|---|
3-Nitropropionic acid | 504-88-1 |
ExUns: | 1 | ^ | 2a | · | 2b | · | 2c | ^ | 3 | ^ | 4 | ^ | 5a | · | 5b | ^ | 6 | ^ | 7 | ^ | 8a | · | 8b | · | 8c | · | 8d | · | 8e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | |||||||||||||||||||||||||
SP2: | - | - | - | ||||||||||||||||||||||||||
SP3: | - | - | |||||||||||||||||||||||||||
SP4: | - | ||||||||||||||||||||||||||||
SP5: | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||
SP6: | - | - | - | - | - | - | - | - | |||||||||||||||||||||
SP7: | - | - | - | - | - | - | - | ||||||||||||||||||||||
SP8: | - | - | - | - | - | - | |||||||||||||||||||||||
SP9: | - | - | - | - | - | ||||||||||||||||||||||||
SP10: |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | BDNF 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | BDNF 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | BDNF 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Bdnf 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Bdnf 30 |
|
||
Cow (Bos Taurus) |
Mammalia | BDNF 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | BDNF 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | BDNF 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | BDNF 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | bdnf 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | bdnf-A 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | bdnf 30 31 |
|
OneToOne |
SNP ID | Clinical significance and condition | Chr 11 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
709884 | Likely Benign: not provided | 27,658,148(-) | G/A | SYNONYMOUS_VARIANT | |
712726 | Benign: not provided | 27,658,019(-) | G/A | SYNONYMOUS_VARIANT | |
718660 | Benign: not provided | 27,657,926(-) | C/T | SYNONYMOUS_VARIANT | |
736217 | Benign: not provided | 27,658,244(-) | G/C | NON_CODING_TRANSCRIPT_VARIANT,SYNONYMOUS_VARIANT | |
743862 | Likely Benign: not provided | 27,658,082(-) | G/A | SYNONYMOUS_VARIANT |
Disorder | Aliases | PubMed IDs |
---|---|---|
central hypoventilation syndrome, congenital |
|
|
wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome |
|
|
mood disorder |
|
|
fetal alcohol spectrum disorder |
|
|
cerebral artery occlusion |
|
|